M
Mario Galli
Researcher at Catholic University of the Sacred Heart
Publications - 30
Citations - 1645
Mario Galli is an academic researcher from Catholic University of the Sacred Heart. The author has contributed to research in topics: Myocardial infarction & Stent. The author has an hindex of 13, co-authored 27 publications receiving 1428 citations.
Papers
More filters
Journal ArticleDOI
Radial versus femoral access in patients with acute coronary syndromes undergoing invasive management: a randomised multicentre trial
Marco Valgimigli,Andrea Gagnor,Paolo Calabrò,Enrico Frigoli,Sergio Leonardi,Tiziana Zaro,Paolo Rubartelli,Carlo Briguori,Giuseppe Andò,Alessandra Repetto,Ugo Limbruno,Bernardo Cortese,Paolo Sganzerla,Alessandro Lupi,Mario Galli,Salvatore Colangelo,Salvatore Ierna,Arturo Ausiello,Patrizia Presbitero,Gennaro Sardella,Ferdinando Varbella,Giovanni Esposito,Andrea Santarelli,Simone Tresoldi,Marco Stefano Nazzaro,Antonio Zingarelli,Nicoletta De Cesare,Stefano Rigattieri,Paolo Tosi,Cataldo Palmieri,Salvatore Brugaletta,Sunil V. Rao,Dik Heg,Martina Rothenbühler,Pascal Vranckx,Peter Jüni +35 more
TL;DR: In patients with acute coronary syndrome undergoing invasive management, radial as compared with femoral access reduces net adverse clinical events, through a reduction in major bleeding and all-cause mortality.
Journal ArticleDOI
Management and Long-Term Prognosis of Spontaneous Coronary Artery Dissection
Corrado Lettieri,Dennis Zavalloni,Roberta Rossini,Nuccia Morici,Federica Ettori,Ornella Leonzi,Azeem Latib,Marco Ferlini,Daniela Trabattoni,Paola Colombo,Mario Galli,Giuseppe Tarantini,Massimo Napodano,Emanuela Piccaluga,Enrico Passamonti,Paolo Sganzerla,Alfonso Ielasi,Micol Coccato,Alessandro Martinoni,Giuseppe Musumeci,Roberto Zanini,Battistina Castiglioni +21 more
TL;DR: In this large observational study of patients with SCAD, angiographic features significantly influenced the treatment strategy, providing an excellent short- and long-term prognosis.
Journal ArticleDOI
Comparison of sirolimus-eluting and bare metal stent for treatment of patients with total coronary occlusions: results of the GISSOC II-GISE multicentre randomized trial
Paolo Rubartelli,Anna Sonia Petronio,Vincenzo Guiducci,Paolo Sganzerla,Leonardo Bolognese,Mario Galli,Imad Sheiban,Fabio Chirillo,Angelo Ramondo,Sandro Bellotti +9 more
TL;DR: In CTO, SES is markedly superior to BMS in terms of restenosis and reocclusion rate, and incidence of repeat revascularization at 24 months, according to a multicentre, randomized trial.
Journal ArticleDOI
Acute and mid-term results of phosphorylcholine-coated stents in primary coronary stenting for acute myocardial infarction.
Mario Galli,Luigi Sommariva,Francesco Prati,S Zerboni,Alessandro Politi,Roberto Bonatti,Stefano Mameli,Elena Butti,Alberto Pagano,Giovann Ferrari +9 more
TL;DR: Primary stenting with phosphorylcholine‐coated stent leads to excellent short‐ and mid‐term clinical outcomes and is associated with a restenosis rate of 12%.
Journal Article
Italian BiodivYsio open registry (BiodivYsio PC-coated stent): study of clinical outcomes of the implant of a PC-coated coronary stent.
Mario Galli,Antonio L. Bartorelli,Francesco Bedogni,Nicoletta DeCesare,Silvio Klugmann,Luigi Maiello,Florenzo Miccoli,Tiziano Moccetti,Marco Onofri,Vito Paolillo,Raimondo Pirisi,Patrizia Presbitero,Paolo Sganzerla,Maurizio Viecca,S Zerboni,Giorgio Lanteri +15 more
TL;DR: It appears that the BiodivYsio stent should be considered safe in clinical and/or anatomical situations with a high risk of complications, confirming the hypothesis that PC may have non-thrombogenic properties.